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Abstract
Lipid storage droplet protein 5 (LSDP5) is a lipid droplet-associated protein of the PAT (perilipin, adipophilin, and TIP47)
family that is expressed in the liver in a peroxisome proliferator-activated receptor alpha (PPARa)-dependent manner;
however, its exact function has not been elucidated. We noticed that LSDP5 was localized to the surface of lipid droplets in
hepatocytes. Overexpression of LSDP5 enhanced lipid accumulation in the hepatic cell line AML12 and in primary
hepatocytes. Knock-down of LSDP5 significantly decreased the triglyceride content of lipid droplets, stimulated lipolysis,
and modestly increased the mitochondrial content and level of fatty-acid b-oxidation in the mitochondria. The expression of
PPARa was increased in LSDP5-deficient cells and required for the increase in the level of fatty acid b-oxidation in LSDP5-
deficient cells. Using serial deletions of LSDP5, we determined that the lipid droplet-targeting domain and the domain
directing lipid droplet clustering overlapped and were localized to the 188 amino acid residues at the N-terminus of LSDP5.
Our findings suggest that LSDP5, a novel lipid droplet protein, may contribute to triglyceride accumulation by negatively
regulating lipolysis and fatty acid oxidation in hepatocytes.
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Introduction
Obesity occurs because of an imbalance between energy intake
and expenditure. Most excess energy is stored as triglycerides
(TGs) in lipid droplets in adipose tissue. Overaccumulation of lipid
droplets in non-adipose tissues, such as in the liver, pancreatic
islets, and coronary artery, is often associated with fatty liver, type
2 diabetes, and coronary atherosclerotic heart disease [1,2,3].
However, the mechanisms of lipid droplet formation in these
tissues remain poorly understood.
Lipid droplets are structurally similar to circulating lipoproteins
as both have a core of esterified lipids (primarily TGs, cholesterol
esters, retinol esters, or other lipids depending on the cell type) that
is encased by a phospholipid monolayer and a coat of proteins [4].
The protein components associated with lipid droplet surfaces are
called lipid droplet-associated proteins. Lipid droplet-associated
proteins are involved in the formation, maturation, secretion, and
trafficking of lipid droplets and participate in regulating of lipid
metabolism in cells, including both lipolysis and lipogenesis
[5,6,7,8]. The best characterized lipid droplet-associated protein
is perilipin, which shares sequence similarity with two other lipid
droplet-associated proteins, adipophilin/adipocyte differentiation-
related protein (ADRP) and tail-interacting protein 47 (TIP47).
Together, these proteins form the PAT (perilipin-adipophilin-
TIP47) family of proteins, and S3-12 has recently been classified in
this family [6]. Perilipin is a phosphoprotein involved in hormone-
stimulated lipolysis, and its expression is restricted to adipocytes
[9]. Adipophilin is ubiquitously expressed, and functions in
limiting the interaction of lipases with the neutral lipids within
droplets, which promotes neutral lipid accumulation [6]. TIP47
and S3-12 coat smaller lipid droplets, where it is possible that they
participate in the early events of lipid droplet formation [6,10].
Lipid storage droplet protein 5 (LSDP5)/perilipin-5 is a newly
identified member of the PAT family. The initial identifications
and characterizations of LSDP5 as a lipid droplet-binding protein
were reported by three independent groups, who named the
protein myocardial lipid droplet protein (MLDP), oxidative tissue-
enriched PAT protein (OXPAT), and LSDP5 [11,12,13]. These
studies reported that LSDP5 is ubiquitously expressed in tissues
that exhibit high levels of fatty acid oxidation, including the heart,
skeletal muscle, and liver. LSDP5 RNA and/or protein are
induced in the heart, liver, and skeletal muscle by fasting and in
gastrocnemius muscle by a high-fat diet [11,12,13,14]. Similar to
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regulated by peroxisome proliferator-activated receptor
a (PPARa), a ligand-activated transcription factor belonging to
the nuclear receptor superfamily [6,11,12,13,15]. Stable heterol-
ogous expression of LSDP5 is associated with increased TG
accumulation in oleate-treated COS-7 and OP9 cells [11,13]. To
date, the functional evaluation of LSDP5 has been limited to gain-
of-function studies in cultured cells. No loss-of-function studies by
gene knockout or by RNAi have been reported. The mechanisms
by which LSDP5 promotes the lipid accumulation are also mostly
unknown.
LSDP5 is expressed in the liver [11,12,13], which plays a central
role in energy homeostasis because it is the primary organ of de
novo lipid synthesis, lipid uptake and secretion, fatty acid
oxidation, and production of ketone bodies. In the present study,
we investigated the function of LSDP5 in murine hepatocytes (in
the AML12 cell line and primary mouse liver cells). Our results
provide evidence that LSDP5 is targeted to lipid droplets and plays
an important role in lipid accumulation. This study also reveals the
mechanisms by which LSDP5 promotes TG deposition in lipid
droplets.
Results
LSDP5 Localizes to Lipid Droplets in Hepatocytes
Little is currently known about the subcellular localization of
LSDP5 in liver cells. A vector containing hemagglutinin (HA)-
tagged LSDP5 was transfected into AML12 cells and oleate was
used to promote the enlargement of lipid droplets. As shown in
Figure 1A, HA-LSDP5 staining was visible throughout the
AML12 cells in the absence of oleate. After oleate was added
into the culture medium, HA-LSDP5 staining showed a distinct
ring pattern surrounding the cores of neutral lipids. LSDP5 also
co-localized with enhanced green fluorescent protein (EGFP)-
adipophilin, which is a well-recognized marker of lipid droplets.
To provide further evidence of the intracellular location of
LSDP5, we investigated the subcellular localization of LSDP5 by
biochemical subcellular fractionation and Western blot analysis.
The majority of the LSDP5 protein was detected in the cytosol
under normal conditions, whereas it was mainly detected in the
lipid droplet fraction and cofractionated with adipophilin upon
treatment with oleate (Figure 1B).
The Dynamics of LSDP5 Expression During
TG Accumulation
The expression and subcellular localization of PAT family
members vary over time during the process of lipid droplet
biogenesis and enlargement [10,16,17]. However, little is known
about the specific changes of LSDP5 during this process. The
expression levels of LSDP5 were monitored during TG accumu-
lation (Figure 2A&2B). AML12 cells were exposed to oleate, which
provided the substrate for TG synthesis. As shown in Figure 2A,
the transcriptional level of LSDP5 did not significantly change 2 h
after oleate treatment (P=0.191). However, an increase in LSDP5
mRNA was detectable 6 h after incubation with oleate, and the
level of LSDP5 mRNA was markedly increased after 12 h. The
LSDP5 mRNA level remained high after prolonged incubation
with oleate (24 h). The amount of LSDP5 protein increased in
parallel with the observed increases in its mRNA level, and the
expression of LSDP5 increased in a dose-dependent manner upon
treatment with oleate (Figure 2B). However, the TG content of the
AML12 cells did not exhibit a significant positive correlation with
the transcriptional level of LSDP5 (r=0.826, P=0.085 at different
times [0, 2, 6, 12, or 24 h] after oleate exposure and r=0.905,
P=0.095 at different concentrations [0, 50, 100, or 200 mM]).
Free fatty acids can potentially activate PPARa expression and
PPARa regulates LSDP5 transcription [12,13]. It remains un-
known whether free fatty acids induce LSDP5 by modulating
PPARa activity or through a PPARa-independent mechanism.
We detected the expression of LSDP5 in the presence of the
PPARa agonist (WY14643) as well as in the presence of the
PPARa inhibitor (GW6471) in the absence or presence of oleate
treatment (200 mM, 24 h). As shown in Figure 2C&2D, exposure
of the cells to WY14643 led to increased expression of LSDP5
regardless whether oleate was administered. By inhibiting PPARa,
GW6471 completely abrogated increased LSDP5 expression in
response to oleate stimulation. These results indicate that the
oleate-induced LSDP5 increase in expression is regulated in
a PPARa-dependent manner.
LSDP5 Stimulates the Storage of TG within the Lipid
Droplets of Hepatocytes
To facilitate the study of LSDP5 in lipid metabolism, LSDP5
was overexpressed using an efficient adenovirus expression system
both in the AML12 mouse hepatic cell line (Figure 3A) and in
primary mouse hepatocytes (Figure S1A). As shown in Figure 3B,
lipid droplets were stained using BODIPY (neutral lipid dye).
BODIPY fluorescence increased in cells overexpressing LSDP5.
The mRNA level of adipophilin, a protein that coats lipid droplets,
was increased in cells overexpressing LSDP5 (Figure 3C). The
amount of TGs in cells overexpressing LSDP5 also significantly
increased, compared to control cells, which was determined using
a TG test kit (P=0.014) (Figure 3D). The phenotypes of increased
lipid droplet storage and increased TG contents were also
observed in primary hepatocytes (Figure S1). These data
demonstrate that the overexpression of LSDP5 is associated with
an increased cellular TG content.
LSDP5 Deficiency Inhibits Lipid Droplet Storage in
Hepatocytes
The expression of LSDP5 was knocked down in AML12 cells
(Figure 4A) and in primary mouse hepatocytes (Figure S2A)
using an adenovirus-mediated gene silencing approach to
investigate the effect of LSDP5 deficiency on cell morphology.
BODIPY fluorescence in LSDP5-deficient cells was less than
that in control cells under lipid loading (Figure 4B). The
depletion of LSDP5 significantly reduced the TG content of
AML12 cells (P=0.016), which was analyzed using a TG test
kit (Figure 4D). Decreases in BODIPY fluorescence and TG
levels were also measured in primary mouse hepatocytes upon
depletion of LSDP5 (Figure S2). To further confirm these
results, a cell line was established where LSDP5 was stably
knocked down (AML12-si-LSDP5) (Figure S3A&S3B). As shown
in Figure S3C, the BODIPY-positive signal was reduced in
AML12-si-LSDP5 cells, and the cellular TG content was also
significantly lowered (P=0.010) (Figure S3D).
Collectively, the data from the overexpression and silencing
experiments indicate that LSDP5 plays an important role in TG
accumulation in liver cells.
Effects of LSDP5 Deficiency on TG Metabolism
An appropriate balance between TG synthesis and lipolysis is
crucial for maintaining lipid homeostasis, and an imbalance
between TG synthesis and lipolysis may result in TG accumulation
[3]. AML12 cells were infected with an adenovirus carrying
LSDP5 siRNA (MOI=90) for 24 h and then incubated with
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significant difference in the incorporation of radiolabeled glycerol
or oleate precursor into TGs between the si-LSDP5 and the
control cells, which suggests that the synthesis of TGs was not
affected by LSDP5 silencing.
To determine the rate of lipolysis, AML12 cells lacking
LSDP5 were loaded with [
3H]-oleate for 24 h. After the loading
period, the [
3H]-labeled TGs accounted for 7766.7% and
8067.9% of the total TG content in the si-LSDP5 and si-
control cells, respectively. There was no significant difference
between the si-LSDP5 and si-control cells (P=0.557), which
demonstrated that [
3H]-oleate was successfully incorporated into
TGs after the loading period. The efflux of [
3H]-oleate to the
medium was monitored for 4 h and reflects the rate of lipolysis
in cells. Triacsin C was administrated to block the re-
esterification. As shown in Figure 5B, oleate release was
increased up to 2-fold in AML12 cells lacking LSDP5 after
2h ( P=0.002) and 4 h (P=0.008); indicating that LSDP5
silencing up-regulated the lipolysis level.
Lipolysis is the total of TG hydrolysis and re-esterification. We
used triacsin C to block re-esterification in order to determine the
component of lipolysis that is affected by si-LSDP5. As shown in
Figure 5C, knock-down of LSDP5 equally increased lipolysis in the
Figure 1. LSDP5 was recruited to lipid droplets. (A) AML12 cells were transiently transfected with HA-tagged LSDP5 and incubated with BSA
(control) or oleate (100 mM) overnight. The cells were stained with an anti-HA antibody with BODIPY 493/503 for visualizing lipids (green) and
Hoechst 33258 for visualizing nuclei (blue). Left panels show the immunofluorescent signal (red), middle panels showed BODIPY staining (green), and
right panels show the merged images. HA-LSDP5 exhibited a steady-state faint cytoplasmic staining and decorated lipid droplets after incubating the
cells in oleate-rich medium. AML12 cells were co-transfected with HA-LSDP5 and EGFP-adipophilin. The cells were incubated with a mouse anti-HA
antibody (primary antibody) and a Cy3-conjugated anti-mouse antibody (secondary antibody). The samples were detected by fluorescence
microscopy (Olympus, Temecula, CA). The results show the co-localization of LSDP5 with adipophilin, a lipid droplet-targeted protein (last row). Scale
bar=5 mm. (B) LSDP5 was enriched in lipid droplet fractions. a-tubulin, a cytosol marker; His, a nucleus marker; and adipophilin, a lipid droplet
marker. 5 mg of each fraction was loaded for immunoblot analysis.
doi:10.1371/journal.pone.0036712.g001
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modulates TG hydrolysis and does not affect re-esterification.
Acetyl-CoA carboxylase 1 (ACC1), fatty acid synthase (FAS),
1-O-acylceramide synthase (ACS), 1-acyl-sn-glycerol-3-phosphate
acyltransferase b (AGPAT2) and adipose triglyceride lipase
(ATGL) have been reported to be crucial to TG metabolism in
vitro and liver steatosis in vivo [18]. Therefore, these genes
were tested in this study. When LSDP5 was knocked down,
there was no significant change in the mRNA levels of ACC1
and FAS, the key enzymes in fatty acid synthesis, or ACS and
AGPAT2, the enzymes that regulated the TG synthesis.
However, knock-down of LSDP5 increased the mRNA level
of ATGL, an important lipolysis enzyme (Figure 5D). LSDP5
silencing increased the ATGL protein level in the total lysate
but decreased the concentration of ATGL on lipid droplets
(Figure 5E).
These data indicate that the loss of LSDP5 increases lipolysis in
liver cells, especially TG hydrolysis.
Effects of LSDP5 Deficiency on Fatty Acid b-Oxidation in
Mitochondria
Mitochondrial fatty acid b-oxidation was studied in LSDP5-
depleted AML12 cells. The oxidation of oleate was assayed by
analyzing the oxidation products in the media after the cells
were labeled with radioactive oleate. In cells with LSDP5
depletion, we observed an increase in oxidation of labeled oleate
(Figure 6A). Real-time PCR analyses revealed that knock-down
of LSDP5 increased the mRNA level of carnitine palmitoyl-
transferase1a (CPT1a) (the rate-limiting enzyme in fatty acid b-
oxidation) and a-subunit of succinate dehydrogenase (Sdha) (an
enzyme in long-chain fatty acid oxidation) (Figure 6B). By
labeling the mitochondria with MitoTracker Red, we observed
that the mitochondrial signal was greater in LSDP5-depleted
cells compared with the control cells (Figure 6C). The amount
of mitochondrial DNA (mtDNA) also increased in LSDP5-
depleted AML12 cells compared with that in the control group
(Figure 6D). In LSDP5 knock-down cells, we observed
Figure 2. The effect of oleate exposure on the expression of LSDP5. (A) AML12 cells were incubated with 200 mM oleate for the indicated
time. Representative Western blots are shown (top panel), and LSDP5 transcript levels were measured using real-time PCR (middle panel). Expression
levels of LSDP5 are expressed as a ratio to a-tubulin (representative of three experiments).
*P,0.05,
**P,0.01,
***P,0.001. The relative mRNA level
before oleate exposure (0 h) was designated as 1.0. n=6,
**P,0.01,
***P,0.001. The amount of TGs in AML12 cells treated with oleate for different
times was assessed with a TG test kit, and is expressed as mg TG/mg protein (bottom panel). n=5,
*P,0.05,
**P,0.01,
***P,0.001. Data are presented
as the mean6SEM. (B) AML12 cells were incubated with different concentrations of oleate (0, 50, 100, and 200 mM) for 24 h. Protein extracts were




amount of TGs in AML12 cells treated with different concentration of oleate was assessed with a TG test kit (bottom panel). n=5,
*P,0.05. Data are
presented as the mean6SEM. (C,D) Effect of WY14643 or GW6471 on oleate-induced LSDP5 expression in AML12 cells. AML12 cells were exposed to
oleate (200 mM) in the absence or presence of WY 14643 (30 mM) or GW6471 (10 mM) for 24 h. The expression of LSDP5 (top panel) and PPARa
(middle panel) was monitored by Western blotting. LSDP5 transcript levels were measured using real-time PCR (bottom panel). The relative mRNA
level of AML12 cells in equivalent amounts of BSA was designated as 1.0. Data are presented as the mean6SEM (n=4–6),
*P,0.05,
**P,0.01,
***P,0.001 (Dunnett’s post hoc test following a one-way ANOVA).
doi:10.1371/journal.pone.0036712.g002
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oxidase subunit IV (Cox4) and cytochrome c oxidase subunit
VIIa polypeptide 1 (Cox7a1); both of these genes encode
components of the mitochondrial respiratory chain (Figure 6B).
This finding is consistent with the observation that the number
of mitochondria increase in LSDP5-deficient cells.
PPARa is Required for the Increase in Datty Acid
Oxidation in LSDP5-Deficient Cells
PPARa plays a critical role in stimulating fatty acid oxidation in
the liver [15]. LSDP5 has been shown to be a PPARa target gene,
and its expression depends both on the physiological conditions
and action of PPARa [13]. We hypothesized that down-regulation
Figure 3. The overexpression of LSDP5 increased cellular TG storage in AML12 cells. (A) Adenovirus-mediated HA-LSDP5 overexpression
in AML12 cells was confirmed by Western blotting. Expression levels of LSDP5 are expressed as a ratio to a-tubulin (representative of three
experiments). (B) AML12 cells were infected with adenovirus encoding LSDP5 for 6 h and then incubated with 200 mM oleate for 24 h. Neutral lipids
were stained with BODIPY 493/503, and nuclei were labeled with Hoechst 33258. The immunofluorescent signals of both BODIPY 493/503 (green)
and Hoechst 33258 (blue) are shown in the merged panels. The BODIPY immunofluorescent signals are shown in the BODIPY493/503 panels and
were edited to grayscale to provide clearer lipid signals and reduce interference from the immunofluorescent signal of the nucleus. Scale
bar=15 mm. (C) The relative mRNA levels of LSDP5 and adipophilin were assessed using real-time PCR. Data are presented as the mean6SEM (n=4),
*P,0.05. (D) A higher concentration of TGs was observed in cells overexpressing LSDP5 compared with controls. Data are presented as the
mean6SEM (n=5),
*P,0.05. Data in this figure were analyzed with paired Student’s t test.
doi:10.1371/journal.pone.0036712.g003
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fatty acid b-oxidation observed in LSDP5-deficient hepatocytes
might be due to an up-regulation of PPARa. Although the mRNA
and protein levels of PPARa were not significantly different
between the si-control and si-LSDP5 groups (Figure 7A&7C), the
PPARa activity was nearly 3-fold greater in the LSDP5-deficient
cells than in the control cells (Figure 7B). The expression levels of
two classical PPARa target genes, CPTIa and acyl CoA oxidase
(ACO), were significantly increased when LSDP5 was knocked
down (Figure 7A&C). The level of oleate oxidation was increased
in LSDP5-deficient cells. However, when PPARa was inhibited by
GW6471, the level of fatty acid oxidation was not significantly
different between the si-LSDP5 and si-control cells (Figure 7D),
indicating that PPARa was required for the increase in the level of
fatty acid oxidation in LSDP5-deficient cells. These data show that
increased fatty acid b-oxidation in LSDP5-deficient cells is
mediated by PPARa activation.
The N-Terminus of LSDP5 is Essential for TG
Accumulation and Lipid Droplet Targeting
The function of proteins can often be ascribed to specific
domains. To determine the domains of LSDP5 involved in TG
accumulation and lipid droplet localization, we constructed
truncations of LSDP5 according to structural analysis of hydro-
phobicity and sequence comparisons with other PAT members
[11,19]. An HA tag was fused to the N-terminal start codon of
mouse LSDP5, and this construct was transiently transfected into
293T cells that were subsequently labeled with an anti-HA
antibody. Consistent with previous reports [11,12], the truncated
proteins containing the N-terminal region of LSDP5 (1–188 aa)
were observed in the lipid fraction and the proteins lacking this
region appeared to lose their capacity to target lipid droplets
(Figure 8A). Using a TG test kit, we determined that the TG
content of cells containing LSDP5 (1–188 aa), LSDP5 (1–382 aa),
LSDP5 delete (188–382 aa) (LSDP5 construct with amino acids
188 382 deleted), and LSDP5 (1–463 aa) was significantly higher
than in other groups (Figure 8B) (P,0.05). LSDP5 constructs
containing residues 1–188 showed more lipid clustering. This
observation suggests that the N-terminal region of LSDP5, which
contains a PAT-1 domain and 11-mer a-helical repeats, is critical
for the lipid droplet localization of LSDP5 and directs TG
accumulation (Figure 8C).
The TG content of cells with full-length LSDP5 (1–463 aa) was
much higher than that of cells expressing LSDP5 (1–188 aa)
(Figure 8B), indicating that the other domains of LSDP5 might
also play roles in TG accumulation.
Figure 4. LSDP5 deficiency inhibited TG accumulation in AML12 cells. AML12 cells were infected with an adenovirus carrying LSDP5 siRNA
for 24 h and then incubated with 200 mM oleate for another 24 h. (A) Western blotting revealed that the adenovirus (si-LSDP5) at a multiplicity of
infection (MOI) of 90 successfully silenced LSDP5 in AML12 cells (.95% knock-down). Expression levels of LSDP5 are expressed as a ratio to a-tubulin
(representative of three experiments). Data are presented as the mean6SEM.
*P,0.05,
**P,0.01 (Dunnett’s post hoc test following a one-way
ANOVA). (B) BODIPY staining of AML12 cells expressing control siRNA (left) or LSDP5 siRNA (right). Scale bar=15 mm. (C) The mRNA levels of LSDP5
and adipophilin were assessed with real-time PCR. The relative mRNA level in AML12 cells infected with an adenovirus containing control siRNA was
designated as 1.0. Data are presented as the mean6SEM (n=4),
*P,0.05. (D) A lower concentration of TGs was detected in si-LSDP5 cells, compared
with control cells. Data are presented as the mean6SEM (n=5),
*P,0.05 (paired Student’s t test).
doi:10.1371/journal.pone.0036712.g004
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Both the formation and break-down of intracellular lipid
droplets are regulated by lipid droplet-associated proteins, a group
of specific proteins located on the lipid droplets that play
important roles in regulating lipid droplet formation, morphology,
and lipolysis [3,10]. Many proteins have been observed to be
associated with lipid droplets, including the PAT family (perilipin,
adipophilin, TIP47, S3-12, and LSDP5), the cell death-inducing
DFF45-like effector (CIDE) family (CIDEA, CIDEB, and
CIDEC/FSP27), caveolin 1, SNARE proteins, lipid-synthesizing
enzymes, lipases (hormone-sensitive lipase/HSL and ATGL), and
the RAB family of GTPases [6,8,20]. Our previous studies have
shown that two lipid droplet-associated proteins, CIDEB and
CIDEC, play important roles in lipid homeostasis, whereas
CIDEB mediates very low-density lipoprotein (VLDL) lipidation
and maturation, and CIDEC influences the differentiation of
human adipocytes [21,22,23]. In this study, we examined the
cellular localization and physiological functions of LSDP5 in liver
cells and confirmed that LSDP5 is targeted to the surface of lipid
droplets and promotes TG accumulation by regulating lipolysis
and fatty acid b-oxidation.
Using an immunofluorescence assay and subcellular fraction-
ation, we demonstrated that LSDP5 is localized to lipid droplets
in hepatocytes (Figure 1). The domains directing lipid droplet
targeting and clustering overlaps and are localized to the 188
residues at the N-terminus of LSDP5 (Figure 8). Amino acids at
the C-terminus also function in lipid accumulation (Figure 8B).
The expression of LSDP5 is sustained at an increased level
under lipid loading (Figure 2), which indicates that LSDP5 might
continuously affect the formation of lipid droplets and contribute
to their enlargement and accumulation. To test this hypothesis, the
effects of overexpressing and silencing LSDP5 were investigated in
the hepatic cell line AML12 and in primary hepatocytes by loss-of-
function and gain-of-function studies. Similar to the results in
COS-7 and OP9 cells [13], overexpression of LSDP5 increases
TG accumulation in liver cells (Figure 3). In contrast, the
suppression of LSDP5 decreases TG content in liver cells
(Figure 4). These data demonstrate that LSDP5 plays an
important role in TG accumulation.
The specific mechanism responsible for TG accumulation
mediated by LSDP5 is unclear. Our results revealed that
depletion of LSDP5 results in increased TG lipolysis in
hepatocytes (Figure 5&6). To clarify whether the increased
TG lipolysis is due to changes in re-esterification, triacsin C was
used to block the effects of long chain fatty acyl CoA synthetase
(LCFACoAS) and isolate the effects of TG hydrolysis on
lipolysis. The results demonstrate that silencing of LSDP5
mainly affects TG hydrolysis but has little effect on re-
Figure 5. Triglyceride synthesis and lipolysis in AML12 cells lacking LSDP5. (A) Incorporation of [
3H]-glycerol or [
3H]-oleate into TG in
control and si-LSDP5 cells. Data were normalized to the number of cells and are expressed as the mean6SEM (n=4). (B) Time courses of [
3H]-oleate
release from si-control and si-LSDP5 cells. Trypan blue staining was used to count the living cells. Data were normalized based on cell viability and
total protein content. Data are presented as the mean6SEM (n=4),
**P,0.01. (C) The effect of LSDP5 silencing on re-esterificaiton and hydrolysis.
After lipid loading, the [
3H]-oleate release after 4 h with or without triacsin C was assessed. The efflux of [
3H]-oleate without triacsin C reflected the
total lipolysis level, the efflux of [
3H]-oleate with triacsin C reflected the TG hydrolysis level, and the difference between TG hydrolysis and total
lipolysis reflected the level of re-esterification. Data were normalized based on cell viability and total protein level. Data are presented as the
mean6SEM (n=4–5),
*P,0.05. (D) The mRNA levels of ACC1, FAS, ACS, AGPAT and ATGL were assessed using real-time PCR. The relative mRNA level
in the control group was designated as 1.0. Data are presented as the mean6SEM (n=6),
*P,0.05. (E) Lipid droplet fractions were isolated by
subcellular fractionation and analyzed by immunoblotting for LSDP5, adipophilin, and ATGL. 20 mg of total hepatocyte lysate and 5 mg of lipid
fraction were loaded for immunoblotting analysis. Expression levels of ATGL are expressed as a ratio to a-tubulin in the total lysate and as a ratio to
adipophilpin on lipid droplets (representative of four experiments). Data are presented as the mean6SEM,
*P,0.05. Data in this figure were analyzed
with paired Student’s t tests.
doi:10.1371/journal.pone.0036712.g005
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activation at the lipid droplet water/oil interface [3,24]. It has
been reported that LSDP5 interacts with lipase HSL, ATGL
and its protein activator, a-b hydrolase domain-containing 5
(Abhd5) on lipid droplet surfaces [25,26,27]. The interaction of
ATGL with LSDP5 decreases lipolysis [28]. Moreover, the liver
has been reported to lack HSL, and ATGL is considered the
most important lipases in liver cells [18]. Thus, we hypothesize
that LSDP5 silencing enhances lipolysis by regulating ATGL
activity. Interestingly, we observed that the mRNA level of
ATGL is increased in hepatocytes when LSDP5 is silenced
(Figure 5D) and that the protein level of ATGL shows a mild
increase in the total lysate. In contrast, the level of ATGL
protein localized to lipid droplets decreases in LSDP5-silenced
cells (Figure 5E). Given that LSDP5 is no longer controlling the
concentration of ATGL on the droplets, the increased level of
ATGL expression might be a compensatory effect in response to
the inability of LSDP5 to localize to lipid droplets. These results
do not support the hypothesis that ATGL is involved in lipolysis
during LSDP5 deficiency. Additional studies will be required to
verify the potential players in lipolysis upon loss of LSDP5. It
will also be interesting to investigate if the ATGL-LSDP5
interaction is domain-specific for LSDP5 and what roles ATGL
plays when LSDP5 is depleted.
In addition, we determined that fatty acid b-oxidation in the
mitochondria is up-regulated when LSDP5 is knocked down
(Figure 6). It remains unclear whether the increase in the level of
fatty acid oxidation is a direct effect of LSDP5 deficiency or an
Figure 6. Depletion of LSDP5 increased fatty acid b-oxidation and the number of mitochondria. AML12 cells were infected with
adenovirus carrying LSDP5 siRNA (MOI=90) or an adenovirus carrying control siRNA for 24 h. (A) b-oxidation of [
3H]-oleate in si-control or si-LSDP5
cells. Data are presented as the mean6SEM (n=4),
*P,0.05. (B) The mRNA levels of CPT1a, Sdha, Cox4 and Cox7a1 were assessed using real-time
PCR. The relative mRNA level in the control group was designated as 1.0. Data are presented as the mean6SEM (n=5),
*P,0.05. (C) Mitochondria in
hepatocytes containing control-siRNA or LSDP5-siRNA were stained with MitoTracker Red. Nuclei were labeled with Hoechst 33258. Scale bar=5 mm.
*P,0.05. (D) Changes in the copy number of mtDNA were assessed with real-time PCR. The relative amount of mtDNA was calculated as the
normalized ratio of NADH dehydrogenase subunit I/lipoprotein lipase, and the relative mtDNA copy number in the control group was designated as
1.0. Data are presented as the mean6SEM (n=4),
*P,0.05. Data in this figure were analyzed with paired Student’s t tests.
doi:10.1371/journal.pone.0036712.g006
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that PPARa is required for the increase in the level of fatty acid
oxidation in LSDP5-deficient cells, implying that LSDP5 in-
directly affects fatty acid oxidation.
TG synthesis is also a critical metabolic pathway contributing to
the lipid content in cells. The rate of TG synthesis is not changed
when LSDP5 is down-regulated (Figure 5A). In vivo, the de novo
synthesis of fatty acids is primarily regulated by ACC1 and FAS.
TG synthesis is regulated by different enzymes, such as ACS and
AGPAT. However, we did not detect significant changes in the
transcription levels of these enzymes (Figure 5D). It is unlikely that
LSDP5 has a direct effect on TG synthesis because the expression
of LSDP5 can be induced in liver cells either by fasting (fat
mobilization) [13] or administration of free fatty acids. The effect
of LSDP5 on the secretion of TG from the liver is an area of active
investigation.
It seems paradoxical that PPARa (which stimulates lipolysis and
fatty acid oxidation) induces LSDP5 (which functions to limit
lipolysis). Most PAT genes are transcriptionally regulated by
PPARs; S3-12 and perilipin are regulated by PPARc; adipophilin
is regulated by PPARa and PPARb/d; and TIP47 does not appear
to be regulated by PPARs. In the liver, the transcription of LSDP5
is regulated by PPARa [15]. However, all PAT proteins, with the
exception of S3-12, have been observed to prevent the lipolysis of
lipid droplets [6,11,12,13]. These observations allow us to
speculate that PAT family proteins determine the properties of
lipid droplets in terms of the storage and mobilization of lipids.
This function has been most extensively studied for perilipin,
which inhibits lipolysis in its non-phosphorylated form and
stimulates lipolysis when phosphorylated [6,10]. Based on the
current functional data [6,16], and the high degree of primary
sequence similarity among PAT family members [12,13,14,19], it
is likely that LSDP5 could also serve as a regulator of both
consumption and accumulation of lipids in the liver, which would
be similar to perilipin in adipose tissue. A more comprehensive
study on the dual role of LSDP5 involving amino acid sequence
analysis and protein-protein interactions is currently being
performed to address this hypothesis. Our data also demonstrate
that PPARa is activated when the expression of LSDP5 is silenced,
which suggests that LSDP5 might not only be a downstream target
of PPARa trans-activation, but may also be involved in a feedback-
sensing pathway. Therefore, the levels of PPARa and LSDP5 may
have a reciprocal influence on each other and be maintained in
a dynamic balance.
Conclusion
Our findings suggest that LSDP5 is a novel regulator in
controlling lipid homeostasis in hepatocytes. It may play an
important role in lipid accumulation by regulating lipolysis and
Figure 7. Effect of LSDP5 silencing on PPARa expression and activity. (A) A representative immunoblot for PPARa, LSDP5, CPT1a and ACO as
detected by chemiluminescence. Expression levels of each protein are expressed as a ratio to a-tubulin (representative of four experiments). Data are
presented as the mean6SEM,
*P,0.05,
**P,0.01. (B) PPARa activity was determined by a binding assay using nuclear protein from si-control and si-
LSDP5 cells and an oligonucleotide corresponding to the PPARa consensus sequence. The activity of PPARa significantly increased when LSDP5 was
knocked down. The results are presented as the absorbance at 450 nm (A450) wave length/mg protein. Data are presented as the mean6SEM (n=5),
*P,0.05. (C) Quantitative analysis of the mRNA level of using LSDP5, CPT1a and ACO as determined by real-time PCR and expressed relative to the
corresponding siRNA control group. Data are presented as the mean6SEM of three independent experiments. (D) Effect of GW6541 on increased b-
oxidation in LSDP5-depleted hepatocytes. Data are presented as the mean6SEM (n=5),
*P,0.05. Data in this figure were analyzed with paired
Student’s t tests.
doi:10.1371/journal.pone.0036712.g007
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LSDP5 could serve as a potentially important therapeutic target
for the treatment of non-alcoholic fatty liver disease. However,
further studies are necessary to elucidate the role of LSDP5 in
hepatic steatosis in vivo.
Materials and Methods
Ethics Statement
The animal experiments in this study were performed in
accordance with the Guide for the Care and Use of Laboratory
Animals of the National Institutes of Health and approved by the
Ethical Committee of Fourth Military Medical University (Permit
number:SCXK2007-007). All surgery was performed under
sodium pentobarbital anesthesia, and all efforts were made to
minimize animal suffering.
Antibodies and Reagents
The affinity-purified rabbit polyclonal LSDP5 antibody was
generated as previously described [29,30] and was also purchased
from Thermo Scientific (catalog no.PT-46215, Bonn, Germany).
The specificities of the LSDP5 antibodies were confirmed by
Western blot analysis (Figure S4). Guinea pig polyclonal anti-
adipophilin (catalog no. RDI-PROGP40) was obtained from
Research Diagnostics Inc (New Jersey, USA). Monoclonal HA
antibody (catalog no. H9658) and monoclonal a-tubulin antibody
(catalog no. T9026) were purchased from Sigma (St. Louis, USA).
Rabbit polyclonal PPARa antibody (catalog no. sc-9000), goat
polyclonal CPT1a antibody (catalog no. sc-20514) and rabbit
polyclonal ACO antibody (catalog no. sc-98499) were obtained
from Santa Cruz Biotechnology (California, USA). Mouse mono-
clonal His antibody (catalog no. 34698) was purchased from
Qiagen (Valencia, USA). Rabbit polyclonal ATGL antibody
(catalog no. #2138) was obtained from Cell Signaling (Beverly,
Figure 8. Effect of LSDP5 constructs on lipid accumulation. (A) 293T cells transfected with truncated HA-LSDP5 were incubated with 100 mM
oleate overnight to enlarge the lipid droplets. Upper panel: The total lysates were subjected to Western blot analysis. An anti-HA antibody was used
to show the expression levels of the HA-LSDP5 truncations used in the experiment. Lower panel: the lipid fraction was isolated by subcellular
fractionation and analyzed by immunoblotting with HA and adipophilin antibodies. (B) The amount of TGs in cells transfected with truncated LSDP5
was quantified using a TG test kit. The TG content under each condition was normalized to the cellular protein level and expressed as a fold change




(Dunnett’s post hoc test following a one-way ANOVA). (C) Schematic illustration of the roles of truncated forms of LSDP5 in lipid targeting and lipid
accumulation.
doi:10.1371/journal.pone.0036712.g008
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purchased from Invitrogen (Carlsbad, USA). Collagenase type II
was obtained from Sigma. Fatty acid-free bovine serum albumin
(BSA) was purchased from Calbiochem (La Jolla, USA) and oleate
was obtained from Sigma. BODIPY 493/50, Nile red and
MitoTracker Red CMXRos were purchased from Invitrogen
(Carlsbad, USA). [9, 10
23H] oleate and [2
23H] glycerol was
obtained from Amersham Pharmacia Biotech (Milan, Italy), and
scintillation liquid (OptiFluor) was purchased from Perkin Elmer
(Boston, USA). Thin-layer chromatograph (TLC) plates were
obtained from Merck (Darmstadt, Germany), and the internal
standards cholesterol, cholesteryl oleate, phosphatidylcholine and
TG were purchased from Sigma. Selective PPARa agonist WY
14643 and PPARa antagonist GW6471 were obtained from
Sigma.
Cell Culture
AML12 cells (American Type Culture Collection, Manassas,
USA) were cultured in DMEM/Ham’s F12 medium supplemen-
ted with 10% fetal bovine serum (FBS) (5 mg/ml insulin, 5 mg/ml
transferrin, 5 mg/ml selenium, 40 ng/ml dexamethasone, 100
units/ml penicillin and 100 mg/ml streptomycin). Cell culture
reagents and FBS were purchased from GIBCO (Gland Island,
USA).
Oleate-containing media was prepared as previously described
[31]. Briefly, oleate was dissolved in ethanol to a concentration of
200 mM and then combined with 10% fatty acid-free BSA
(5 mM). The pH of the solution was adjusted to 7.5, and the oleate
stock solution was filter-sterilized and stored at 220uC. A control
solution containing ethanol and BSA was similarly prepared. For
individual experiments, the culture medium was removed and
replaced by 2% FBS-medium containing appropriate stock
solutions.
Mouse Hepatocyte Isolation
Mouse hepatocytes were isolated using a two-step in situ
collagenase perfusion procedure as previously described [22].
Six-week-old C57BL/6 mice were purchased from the Fourth
Military Medical University Animal Center. The livers from the
C57BL/6 mice were perfused in situ through the portal vein
with EGTA buffer (0.5 mM EGTA, 137 mM NaCl,
4.7 mM KCl, 1.2 mM KH2PO4, 0.65 mM MgSO4, and
10.07 mM HEPES at pH 7.4) at a flow rate of 5 ml/min for
10 min, followed by collagenase buffer (67 mM NaCl, 6.7 mM
KCl, 4.76 mM CaCl2, 0.035% collagenase type II, and
10.07 mM HEPES at pH 7.6) at a flow rate of 5 ml/min for
15 min. After centrifugation, the hepatocytes were collected and
seeded in DMEM containing 10% FBS, 100 units/ml penicillin,
and 100 mg/ml streptomycin.
Construction of Expression Plasmids
The full-length and truncated forms of LSDP5 were PCR
amplified using specific primers (Table S1) corresponding to the
regions described in Figure 8C. All of the PCR products contained
a NedI or NcoI restriction site at the 59-end and a BglII restriction
site at the 39-end. The PCR products were digested with NedI/
NcoI and BglII and inserted in-frame into pBluescript KS-HA to
generate HA-tagged constructs. The HA-tagged inserts were
digested with HindIII and XbaI and subcloned into the pCMV5
vector to produce the mammalian expression constructs. The
sequences of all of the constructs were confirmed by DNA
sequencing.
Depletion of LSDP5 in AML12 Cells
The siRNA constructs used to target LSDP5 mRNA were
designed using siRNA TARGET FINDER software (http://
www4.appliedbiosystems.com/techlib/misc/siRNA_finder.html).
The sense oligonucleotide was 59-GGCAAGCACACAAT-
GATGC-39. The specificity of the LSDP5-siRNA is shown in
Figure S5. Oligonucleotides encoding the siRNAs were inserted
into the pSilencer 3.1-H1 neo vector (kindly provided by Dr. Peng
Li, Tsinghua University, China), and the resulting construct was
transfected into AML12 cells using Lipofectamine 2000 (Invitro-
gen, Carlsbad, USA). Approximately 48 h after transfection,
selection medium containing G418 (500 mg/ml) was used to
culture cells for 20 d. The isolated G418-resistant cell clones were
then selected and amplified. An siRNA sequence specific for the
GL2 luciferase gene was used as the control siRNA [32].
Generation of Recombinant Adenovirus
The recombinant adenovirus carrying full-length LSDP5 with
an HA epitope tag on the N-terminal end was constructed using
the AdEasy-1 System (Stratagene, La Jolla, USA). The adenovirus
carrying green fluorescent protein (GFP) (Benyuan Zhengyang
Gene Technology Company Ltd., Beijing, China) was used as
a control. Adenovirus-mediated siRNA of LSDP5 was generated
using the same method. After large-scale amplification of AD293
cells, recombinant adenovirus was purified using CsCl density-
gradient ultracentrifugation, dialyzed against PBS supplemented
with 15% glycerol, and stored at -80uC. To infect cells, Ad-LSDP5
and Ad-GFP (control virus) or Ad-si-LSDP5 and Ad-si-GL2
luciferase (si-control virus) were directly added to primary cultured
hepatocytes or AML12 cells.
Lipid Staining and Mitochondria Staining
Cells were grown on coverslips in 12-well plates. Cell lipids were
stained with Nile red or BODIPY 493/503 as previously described
[22,23]. MitoTracker Red CMXRos was used to stain the
mitochondria according to the manufacturer’s instructions.
Isolation of Lipid Droplets by Subcellular Fractionation
Lipid droplet fractions were isolated by sucrose gradients as
previously described [22]. Briefly, cells (three 150-mm dishes) were
washed with PBS, collected by centrifugation, resuspended in
a hypotonic medium (10 mM HEPES/NaOH (pH 7.4),
1 mM EDTA, 10 mM sodium fluoride, and protease inhibitor
mixture and incubated for 10 min on ice followed by 10 strokes
with a Dounce homogenizer. The lysate was mixed with an equal
volume of disruption buffer containing 1.08 M sucrose. The
homogenates were centrifuged to remove the nuclei, and the
supernatant was overlaid with 2 ml each of 0.27 M sucrose buffer,
0.13 M sucrose buffer, and top buffer (25 mM Tris HCl, 1 mM
EDTA, and 1 mM EGTA). The gradient was centrifuged at
250,000 g 1 h at 4uC in a Beckman XP-100 ultracentrifuge. After
centrifugation, the buoyant lipid droplet fractions were collected
on the top of the gradient. The floating lipid droplet fractions were
harvested by careful suctioning with Pasteur pipets. The proteins
on lipid droplets were precipitated by ice-cold acetone and washed
twice with acetone/diethylether (1:1, vol/vol).
Lipid Analysis
To measure the total TG level, lipids were extracted from cells
using the Folch method [33]. Dried lipids were reconstituted in
chloroform:methanol (2:1, v/v) and assayed using a TG test kit
(WAKO Chemicals, Osaka, Japan). The TG content was
LSDP5 Regulates Lipid Storage
PLoS ONE | www.plosone.org 11 June 2012 | Volume 7 | Issue 6 | e36712normalized to the protein content and measured using the Bio-
Rad Protein assay (Bio-Rad, Hercules, USA).
AML12 cells were infected with an adenovirus carrying LSDP5
siRNA for 24 h and incubated in experimental medium contain-
ing 1 mCi/ml [2
23H] glycerol or 1 mCi/ml [9, 10
23H] oleate
(Amersham Pharmacia Biotech, Milan, Italy). The amounts of
tritium incorporated into the TGs was monitored at 2 h, 4 h, 8 h,
and 12 h. Lipids were extracted from cells using chloroform:-
methanol (1:2; v/v) and were separated using TLC [23]. The TG
spots were scratched off the TLC plates, dissolved in 500 mlo f
methanol:water (1:2; v/v) and counted in 5 ml of scintillation
liquid (OptiFluor) using a beta counter (LS 8000, Beckman
Instruments). To measure cellular lipolysis, cells were incubated in
24-well plates and were treated overnight with 0.4 mCi/well [9,
10
23H] oleate. Following the 24 h loading period, cells were
washed three times with sterile PBS (pH 7.4) and placed in an
efflux medium consisting of DMEM/Ham’s F12 medium that
included 1% fatty acid-free BSA as a fatty acid acceptor. The
efflux of radioactivity into the medium was measured over time.
Re-esterification of the fatty acids was prevented by inclusion of
2.5 mM triacsin C (Santa Cruz, California, USA), an inhibitor
of acetyl co-enzyme A synthetase. Mitochondrial b-oxidation of
[9,10
23H] oleate in AML12 cells was assayed by the degree
of incorporation of
3H into H2O using a liquid scintillation
counter [34]. The results are expressed as disintegrations per
minute (DPM) and are normalized to the protein concentration.
Copy Number of mtDNA
Total DNA was extracted using the Universal Genomic DNA
Extraction Kit (TaKaRa, Tokyo, Japan). The copy number of
mtDNA was determined using real-time PCR as previously
reported [35]. The primers used to assay NADH dehydrogenase
subunit I were sense, 59- CCCATTCGCGTTATTCTT-39
(sense), and antisense, 59- AAGTTGATCGTAACGGAAGC-39
(antisense). The lipoprotein lipase gene was used as a reference for
nuclear DNA quantification and the primers used were sense, 59-
GGATGGACGGTAAGAGTGATTC-39(sense), and antisense,
59- ATCCAAGGGTAGCAGACAGGT -39(antisense).
RNA Extraction and Quantitative Real-Time PCR
Procedures for RNA extraction and real-time PCR analysis
have been previously described [7]. In short, the total RNAs of
tissues or cells was extracted using Trizol reagent according to the
manufacturer’s directions (Invitrogen, CA, USA). Reverse-tran-
script PCR was performed with the reverse transcription kit
(TaKaRa, Shiga, Japan). Primer sequences for real-time PCR
analysis are listed in Table S2. Real-time PCR reaction
components were derived from the SYBR Green Kit (TaKaRa,
Shiga, Japan). PCR products were quantified uorometrically using
SYBR Green, and normalized to the housekeeping gene GAPDH
and relative to the control group according to the following
formula: target amount=2
2ggCt, where 2ggCt={[Ct (target
gene)-Ct (GAPDH)]-[Ct (control)-Ct (GAPDH control)}.
Immunofluorescence Assay and Western Blotting
Immunofluorescence analyses were performed on cells grown
on coverslips. The cells were fixed in a freshly prepared solution of
4% paraformaldehyde, rinsed, and permeabilized with 0.1%
Triton X-100. Permeabilized cells were incubated with 5% goat
serum in PBS to block non-specific binding. After thorough rinsing
with PBS, the cells were incubated 24–48 h at 4uC with a rabbit
anti-HA antibody (diluted 1:5000, Sigma) and incubated with
a Cy3-conjugated anti-mouse antibody (diluted 1:500, Invitrogen).
Specimens were observed using a Zeiss 200 M fluorescence
microscope, and images were captured with an AxioCam MRm
camera and Axio Vision software 4.5 (Zeiss). The images of co-
localization images were captured using laser-scanning confocal
microscopy (FV-300/IX71, Olympus, Tokyo, Japan).
Western blots were performed as previously described [36]. The
working dilutions of primary antibodies were as follows: HA-
antibody (Sigma), 1:5000; LSDP5 antibody (made by our lab),
1:1000; LSDP5-antibody (Thermo), 1:400; PPARa (Santa Cruz),
1:500; adipophilin (RDI), 1:2000; CPT1a (Santa Cruz), 1:400;
ACO (Santa Cruz), 1:200; a-tubulin (Sigma), 1:10,000; and His
(Qiagen), 1:5000.
PPARa Activity Assay
Nuclear extracts were prepared according to the kit instructions
and stored at -80uC until analysis. Activated PPARa from the
nuclear extract was measured by its DNA binding to an
immobilized oligonucleotide containing a PPAR consensus bind-
ing site using the TransBinding PPARa Assay Kit (Panomics,
Redwood City, USA). Binding was assessed by measuring the
absorbance at 450 nm.
Statistical Analysis
Results are expressed as the mean6SEM from the indicated
number of experiments. Data were analyzed with the paired-
sample two-sided Student’s t-tests for paired samples and one-way
ANOVA tests and Dunnett’s post hoc tests for comparisons of
multiple groups. All statistical analyses were performed using SPSS
version 11.0 (SPSS Inc., Chicago, USA). A probability level of
0.05 was considered significant.
Supporting Information
Figure S1 LSDP5 overexpression enhanced the cellular
lipid content in primary mouse hepatocytes. Primary
mouse hepatocytes were infected with an adenovirus containing
HA-tagged LSDP5 for 6 h and then incubated with 200 mM
oleate for 24 h. (A) LSDP5 overexpression in mouse primary
hepatocytes was verified by Western blot. (B) Up-regulation of
LSDP5 mRNA in primary mouse hepatocytes. Data are presented
as the mean6SEM (n=4),
*P,0.05. (C) Representative photos
showing LSDP5 overexpression in primary mouse hepatocytes.
Neutral lipids were stained with BODIPY 493/503 and nuclei
were labeled with Hoechst 33258. Scale bar=5 mm. (D) The TG
content in primary mouse hepatocytes overexpressing LSDP5.
Data are presented as the mean6SEM (n=5),
*P,0.05. Data in
this figure were analyzed with paired Student’s t tests.
(TIF)
Figure S2 Suppression of LSDP5 affects lipid storage in
primary mouse hepatocytes. Primary mouse hepatocytes
were infected with adenovirus containing siRNA against LSDP5
for 24 h and incubated with 200 mM oleate overnight. (A) After
infection and lipid loading, Western blotting revealed that the
adenovirus-mediated silencing of LSDP5 effectively reduced the
LSDP5 protein level (at least 90%) from primary mouse
hepatocytes. Similar results were obtained from three independent
experiments. (B) Knock-down of LSDP5 mRNA in primary mouse
hepatocytes was assessed with real-time PCR. Data are presented
as the mean6SEM (n=4),
*P,0.05. (C) Representative photos
showing LSDP5 depletion in primary mouse hepatocytes. Neutral
lipids were stained with BODIPY 493/503, and nuclei were
labeled with Hoechst 33258. Scale bar=5 mm. (D) The TG
content of primary mouse hepatocytes expressing a siRNA
targeting LSDP5. Data are presented as the mean6SEM (n=5),
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(TIF)
Figure S3 Lipid storage was blocked in AML12-si-
LSDP5 cells. (A) The plasmid pSilencer3.1-H1 neo containing
siRNA against LSDP5 was transfected into AML12 cells and was
followed by G418 selection. Two stable clones were selected and
are referred to as AML12-si-LSDP5 (22) and AML12-si-LSDP5
(37). Western blot analysis was performed on AML12 cells,
AML12-si-control cells, AML12-si-LSDP5 (22) cells and AML12-
si-LSDP5 (37) cells using an LSDP5 antibody. Immunoblot
analysis revealed that the expression of LSDP5 was significantly
reduced in the two selected stable clones, especially in AML12-si-
LSDP5 (37) cells. The expression levels of LSDP5 are expressed as
a ratio to a-tubulin (representative of four experiments). Data are
presented as the mean6SEM,
*P,0.05 (Dunnett’s post hoc test
following a one-way ANOVA). AML12-si-LSDP5 (37) cells were
used in the following experiments and are referred to as AML12-
si-LSDP5 for short. (B) Verification of the LSDP5 silencing using
real-time PCR. Data are presented as the mean6SEM (n=4),
*P,0.05. (C) AML12-si-control cells and AML12-si-LSDP5 cells
were incubated with 200 mM oleate for 24 h and stained with
BODIPY 493/503. Scale bar=15 mm. (D) The TG content of
AML12-si-control cells and AML12-si-LSDP5 cells after oleate
supplementation. Data are presented as the mean6SEM (n=5),
*P,0.05 (paired Student’s t test).
(TIF)
Figure S4 The specificity of the LSDP5 antibody. 293T
cells were transfected with pCMV5-HA-LSDP5 encoding full-
length (1–463 aa) LSDP5 (HA-LSDP5) or pCMV5-HA-LSDP5
encoding the carboxy-terminal domain (189–463 aa) of LSDP5
(HA-LSDP5-Ct). Western blotting was performed using an anti-
HA antibody, a commercial LSDP5 antibody (LSDP5 Ab1) and
an LSDP5 antibody generated in this study (LSDP5 Ab2).
(TIF)
Figure S5 The specificity of LSDP5-siRNA. 293T cells
were transfected with pCMV5-HA-LSDP5 (A), pCMV5-HA-
perilipin (B), pCMV5-HA-adipophilin (C), psilencer-si-LSDP5 and
psilencer-si-control as indicated. The expression level of LSDP5,
perilipin or adipophilin was analyzed by Western blotting with an
anti-HA antibody. Each experiment was repeated at least 3 times.
(TIF)
Table S1 Primer sequences for the full-length and
truncated forms of LSDP5.
(DOC)
Table S2 Primer sequences for real-time PCR.
(DOC)
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